The kizuna centrosomal protein, known by the gene symbol KIZ or C2orf39, is an important protein associated with the centrosome in cells. The centrosome is a key cellular structure that plays a crucial role in organizing microtubules and is critical for the process of cell division (mitosis). Kizuna is particularly vital during the mitotic phase, where it helps maintain the integrity of the centrosome and ensures proper mitotic spindle formation.This protein was dubbed "kizuna" because the term means "bonds" in Japanese, reflecting its function in maintaining the cohesive structure of the centrosome during the stressful conditions of cell division. Just as kizuna signifies strong social bonds or ties between people, the kizuna protein helps maintain the structural cohesion between centrioles, the cylindrical structures that comprise the centrosome.
Mutations or dysfunctions in the KIZ gene or the kizuna protein can lead to errors in cell division, which may have implications for various diseases, including cancer, where cell division becomes unregulated. Additionally, proper centrosomal function is crucial for the development and maintenance of organismal complexity, so alterations in proteins like kizuna can have significant developmental consequences.Kizuna's role extends beyond simply holding the centrosome together; it is also involved in the recruitment of other proteins to the centrosome and can influence the timing of cell cycle progression.
VOIR ÉGALEMENT...
| Nom du produit | CAS # | Ref. Catalogue | Quantité | Prix HT | CITATIONS | Classement |
|---|---|---|---|---|---|---|
BI6727 | 755038-65-4 | sc-364432 sc-364432A sc-364432B sc-364432C sc-364432D | 5 mg 50 mg 100 mg 500 mg 1 g | $147.00 $1029.00 $1632.00 $3264.00 $4296.00 | 1 | |
BI 2536 est un inhibiteur de PLK1. Bien qu'il inhibe PLK1, il peut indirectement influencer l'interaction de Kizuna Centrosomal Protein avec PLK1. | ||||||
BI 2536 | 755038-02-9 | sc-364431 sc-364431A | 5 mg 50 mg | $148.00 $515.00 | 8 | |
Volasertib est un autre inhibiteur de PLK1, affectant potentiellement les processus où la protéine centrosomale de Kizuna et PLK1 interagissent. | ||||||
GSK461364 | 929095-18-1 | sc-364504 sc-364504A | 10 mg 50 mg | $500.00 $1540.00 | ||
GSK461364 est un inhibiteur sélectif de PLK1, ce qui pourrait avoir un impact indirect sur la fonction de la protéine centrosomale Kizuna par le biais de la modulation de PLK1. | ||||||
NVP-BHG712 | 940310-85-0 | sc-364554 sc-364554A | 5 mg 50 mg | $232.00 $1764.00 | ||
GW843682X est un inhibiteur de PLK1, qui pourrait indirectement moduler la fonction de la protéine centrosomale Kizuna en influençant PLK1. | ||||||
RO-3306 | 872573-93-8 | sc-358700 sc-358700A sc-358700B | 1 mg 5 mg 25 mg | $65.00 $160.00 $320.00 | 37 | |
RO3280 est un inhibiteur de PLK1, qui pourrait avoir un impact indirect sur la protéine centrosomale de Kizuna par le biais de la modulation de la voie PLK1. | ||||||
LFM-A13 | 62004-35-7 | sc-203623 sc-203623A | 10 mg 50 mg | $119.00 $670.00 | ||
LFM-A13 est un inhibiteur de la Polo-like kinase, qui pourrait indirectement influencer la protéine centrosomale Kizuna par son action sur la PLK1. | ||||||
Purvalanol B | 212844-54-7 | sc-361300 sc-361300A | 10 mg 50 mg | $199.00 $846.00 | ||
Le Purvalanol A, un inhibiteur de la kinase cycline-dépendante, peut indirectement affecter la protéine centrosomale de Kizuna par le biais des voies de régulation du cycle cellulaire. | ||||||